The largest mechanical thrombectomy study in the field of DVT evaluating real world patient outcomes after treatment with the ClotTriever® system.

A lytic-free approach enabling decreased hospital resource utilization

Significant thrombus removal to provide patients with sustained benefits at 30 days

n= 486

Complete or near-complete thrombus removal

n= 393

Free of moderate or severe PTS symptoms at 30 days

Restoring flow with an unmatched safety profile

Device-related SAEs

n= 499

Vessel damage
Valve damage
Acute kidney injury (AKI)

n= 424